Merck Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/28/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. NTNX
9. HPQ
10. A

Go back to Merck Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics
Merck & Co. (NYSE: MRK) Delayed: 149.54 --0 (-0%)
Previous Close $149.54    52 Week High $65.46 
Open $149.54    52 Week Low $47.97 
Day High $149.54    P/E 101.73 
Day Low $149.54    EPS $1.47 
Volume 3,219